Trastuzumab deruxtecan (Enhertu®) is a promising drug for HER2-low metastatic breast cancer, shown to extend patients’ lives and improve their quality of life. This breakthrough represents a great hope in precision medicine for treating difficult cancers.

Arkkosmart is a comprehensive platform for organizations that simplifies identity, payment, and community management with high security.

Microservices enable the transformation and modernization of businesses by offering scalability, resilience, and adaptability to new technologies. By scaling only what’s needed and isolating failures, performance is optimized, and downtime is reduced. Additionally, they accelerate development, allowing for a quick response to market changes.

The financial sector is undergoing significant transformation thanks to the integration of Artificial Intelligence (AI) solutions and open banking. These advancements enable strategic vision, improve operational efficiency, and offer more personalized services. Modernization includes integration, API-fication, and new open banking models, driving innovation and market adaptation.

A 2023 Experian study showed that 74% consider physical biometrics the safest method for digital identity verification. Digital Identity has advanced over 30 years, facing challenges like AI fraud. Estonia is a notable example, with 99% of its public services digitized.

Arkkosoft drives AI innovation to optimize operations, enhance decision-making, and deliver high-quality services. With a specialized R&D team, it develops advanced solutions to ensure its clients remain competitive and efficient.